<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (MDSs) are characterized by peripheral blood cytopenia including <z:hpo ids='HP_0001903'>anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We have investigated the implication of the extrinsic pathway of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:hpo ids='HP_0010972'>ineffective erythropoiesis</z:hpo> by in vitro expansion of erythroid precursors from early stage (low and intermediate-1 International Prognosis Scoring System [IPSS]) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, advanced stage (intermediate-2 IPSS) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, and control bone marrow samples </plain></SENT>
<SENT sid="2" pm="."><plain>We have previously shown that Fas and its ligand were overexpressed in early stage <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> erythroid cells </plain></SENT>
<SENT sid="3" pm="."><plain>Here, we show that caspase-8 activity is significantly increased, whereas the expression of <z:hpo ids='HP_0011420'>death</z:hpo> receptors other than Fas, including the type 1 receptor for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor alpha (TNF-alpha) and the receptors for the TNF-related <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-inducing ligand (TRAIL), DR4 and DR5, was <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>We also observed that the adapter Fas-associated <z:hpo ids='HP_0011420'>death</z:hpo> domain (FADD) was overexpressed in early stage <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> erythroid cells </plain></SENT>
<SENT sid="5" pm="."><plain>Transduction of early stage <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-derived CD34+ progenitors with a FADD-encoding construct <z:mp ids='MP_0006042'>increased apoptosis</z:mp> of erythroid cells and dramatically reduced erythroid burst-forming unit (BFU-E) growth </plain></SENT>
<SENT sid="6" pm="."><plain>Transduction of a dominant-negative (dn) mutant of FADD inhibited caspase-8 activity and cell <z:hpo ids='HP_0011420'>death</z:hpo> and rescued BFU-E growth without abrogating erythroid differentiation </plain></SENT>
<SENT sid="7" pm="."><plain>These results extend the observation that Fas-dependent activation of caspase-8 accounts for <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of early stage <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> erythroid cells and demonstrate for the first time that FADD is a valuable target to correct <z:hpo ids='HP_0010972'>ineffective erythropoiesis</z:hpo> in these syndromes </plain></SENT>
</text></document>